WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹-718 Cr | ₹-1,521 Cr | ₹-762 Cr | ₹-840 Cr | ₹-1,097 Cr |
What is the latest Net Current Assets ratio of WOCKHARDT ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹-718 Cr |
Mar2023 | ₹-1,521 Cr |
Mar2022 | ₹-762 Cr |
Mar2021 | ₹-840 Cr |
Mar2020 | ₹-1,097 Cr |
How is Net Current Assets of WOCKHARDT Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹-718 Cr | Negative | |
Mar2023 | ₹-1,521 Cr | Negative | |
Mar2022 | ₹-762 Cr | Negative | |
Mar2021 | ₹-840 Cr | Negative | |
Mar2020 | ₹-1,097 Cr | - |
Compare Net Current Assets of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹17,193.1 Cr | 9.8% | 12.9% | 378.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹456,509.0 Cr | 0.9% | 0.2% | 66% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,240.0 Cr | -0.2% | 8% | 66.6% | Stock Analytics | |
CIPLA | ₹121,422.0 Cr | -0.5% | -7.3% | 28.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,505.0 Cr | -1.5% | -2.7% | 18.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,293.0 Cr | 1.9% | -5.8% | 72.4% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | 9.8% |
12.9% |
378.6% |
SENSEX | -1.4% |
-6.1% |
23.9% |
You may also like the below Video Courses